BioAge Labs GAAP EPS of -$0.52, revenue of $2.8M
BioAge Labs, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $17.20
-9.0% in 7d after detection
Post-detection moves
1h
—
1d
+0.9%
3d
+6.4%
7d
-9.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS